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1078-5884/$36 ª 2010 European Socie
doi:10.1016/j.ejvs.2010.12.004Abstract This report describes endovascular stenting of an acute mycotic ascending aortic
aneurysm.
An eighty-three year old lady presented nine weeks after aortic valve surgery and subse-
quent thyroidectomy with sternal pain secondary to a mycotic ascending aortic pseudoa-
neurysm. The pseudoaneurysm was visible through the unhealed sternum. Open repair
was considered too high a mortality risk. Endovascular stenting was performed using two
covered infrarenal proximal extension devices (GORE Excluder Aortic Extender, W. L. Gore
& Associates, Flagstaff, Arizona, USA) deployed from a right axillary approach utilising
overdrive cardiac pacing. Post procedure imaging revealed shrinkage of the pseudoaneur-
ysm sac.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
We report a case of an acute, life threatening, mycotic
pseudoaneurysm of the ascending aorta following aorticdoctors.org.uk
ty for Vascular Surgery. Publishevalve replacement, treated successfully by endovascular
stent graft placement.
Case Report
Aneighty-three year old ladyunderwent elective aortic valve
replacement. Her co-morbidities included medicated
hypertension, hyperlipdaemia, non insulin dependent dia-
betes and hyperthyroidism. On extubation following surgery,
she developed respiratory compromise and sufferedd by Elsevier Ltd. All rights reserved.
Figure 1 Pseudoaneurysm presenting as a tender, pulsatile
mass beneath her sternotomy scar.
Endovascular Repair 489a cardiorespiratory arrest requiring cardiac massage and
reintubation. After seven days, she underwent percutaneous
tracheostomy formation. Five weeks, several decannulation
attempts had failed, thought to be due to a retrosternal
goitre causing airway compromise. She underwent total
thyroidectomy facilitating successful decannulation seven
weeks post procedure.Figure 2 Transverse and sagittal sections of the computed tomo
arrow) originating from the ascending aorta (A) with its surrounding
arrow).Over the next two weeks she complained of sternal pain,
developing an 8  6 cm, tender, pulsatile swelling under-
neath her sternotomy scar (Fig. 1). Blood cultures grew
Staphylococcus aureus treated with Rifampicin, Doxycy-
cline and Vancomycin.
Computed Tomography (CT) Angiography demonstrated
a 10 cm pseudoaneurysm arising from the ascending aorta,
2 cm distal to the coronary vessels, with a patent lumen. It
extended through partially disrupted sternal wires with
sternal non-union (Fig. 2).
Open repair was considered but she was deemed
unlikely to survive this and was therefore transferred to our
unit for endovascular treatment. The pseudoaneurysm was
imaged via a catheter in the right brachial artery showing
flow into the sac from a defect distal to the coronary
orifices. With no identifiable single defect in the aortic wall
and a defect too extensive for a patent foramen ovale
closure device, stent graft placement was planned. Via an
open right axillary artery approach, two 26 mm covered
infrarenal proximal extension devices (GORE Excluder
Aortic Extender, W. L. Gore & Associates, Flagstaff, Ari-
zona, USA) were deployed in the ascending aorta, through
an 18F sheath, covering the origin of the pseudoaneurysm,
confirmed on angiography (Fig. 3). Coronary and brachio-
cephalic flow was preserved. Overdrive cardiac pacing
dropped the systolic pressure to 40 mmHg, enabling accu-
rate stent graft placement. The device is designed for
abdominal aortic placement and hence the delivery device
length would not allow a femoral approach.
She was extubated 24 h later and made an uneventful
recovery. CT imaging at 48 h confirmed exclusion of the
pseudoaneurysm, with no contrast extravasation (Fig. 4).
Her sternal swelling settled within one month (Fig. 5). She
remained on life-long Rifampicin and Doxycycline given the
mycotic element of the pseudoaneurysm and risk of life
threatening graft infection and was well four weeks post
discharge.graphy scan demonstrating the pseudoaneurysm (small white
haematoma causing disruption of the sternal wires (large white
Figure 3 Pre and post stenting digital subtraction angiography images showing contrast extravasation in the pseudoaneurysm
(white arrow) and subsequent stent (black arrow) positioning with exclusion of the pseudoaneurysm.
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Pseudoaneurysms are a rare life threatening complication
following aortic valve surgery. Chest pain, fever and heart
failure are common presentations but the pathology may
only be detected incidentally.
Reports describe similar cases presenting with a pulsa-
tile sternal swelling1 but this is rare.
We believe the likely aetiology in this case is infection of
the sutured aortotomy of the aortic valve replacement,
related to either thyroidectomy or tracheostomy.
Traditionally, ascending aortic pseudoaneurysms are
repaired via a sternotomy, associated with high levels of
morbidity and mortality. This requires cardiopulmonary
bypass and deep hypothermic circulatory arrest. TheFigure 4 Transverse and sagittal sections of the computed tomog
(A) with exclusion of the pseudoaneurysm and resultant haematomthirty day survival rate of open aortic pseudoaneurysm
repair has, in some reports, been encouraging, with
survival rates of up to 94% in one study of sixty
patients.2 Other reviews of selected series of patients
describe mortality rates up to 16.5%, with stroke rates of
2e18%.3
Endovascular methods are not without risk. There are
embolisation and stent graft infection risks and techniques
can be limited due to aortic arch anatomy. However,
endovascular repair may still be preferable to open repair
to avoid the inherent risks of a major surgical procedure.
We selected a GORE proximal extension device with its
short nose cone reducing trauma to the aortic valve during
placement. It can be rapidly deployed during overdrive
pacing.raphy scan showing correct stent position in the ascending aorta
a (H).
Figure 5 Resolutionof the sternal swelling onemonth following
stenting.
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aorta experimental. Two reports describe endovascular
stenting of mycotic ascending aortic pseudoaneurysms4,5
but at fifteen and twelve months post procedure respec-
tively, not in the acute setting. Heye et al describe themost recent case post coronary artery bypass grafting,
presenting with haemoptysis.4 A 7 cm pseudoaneurysm
arose from a cannulation site of the aorta and blood
cultures grew S. aureus. As in our case, a GORE Excluder
Aortic Extender device was used.
Conclusion
This endovascular procedure treated a rapidly expanding,
life threatening, acute, mycotic pseudoaneurysm, avoiding
a high-risk open procedure. Advances in technology offer
less invasive procedures for aortic pathologies. Where the
anatomy is suitable, endovascular management of pseu-
doaneurysms of the ascending aorta may be an acceptable
alternative to open repair due to its reduced associated
risks.
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